Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03179709 · ClinicalTrials.gov registry record
Provider Perceptions of Neuromuscular Blockade in ARDS
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 35
- Enrollment target
NCT03179709 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 35 participants.
The verdict
NCT03179709 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The proposed study will use qualitative methodology to understand health care provider perceptions of neuromuscular blockade (NMB) in patients with Acute Respiratory Distress Syndrome (ARDS). To achieve this goal the investigators will conduct a prospective ancillary study at four clinical centers participating in the NHLBI PETAL network as part of the ROSE (Reevaluation of Systemic Early Neuromuscular Blockade) clinical trial (NCT02509078). Using thematic content analysis of semistructured interviews with health care providers caring for patients enrolled in the ROSE trial the investigators will determine the barriers to NMB use and develop a framework for future NMB adoption in ARDS.
Interventions
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2018-03-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03179709
The ClinicalTrials.gov registry entry for NCT03179709 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interview is the first listed.
NCT03179709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03179709 about?
NCT03179709 is a clinical study titled "Provider Perceptions of Neuromuscular Blockade in ARDS". The proposed study will use qualitative methodology to understand health care provider perceptions of neuromuscular blockade (NMB) in patients with Acute Respiratory Distress Syndrome (ARDS). To achieve this goal the investigators will conduct a prospective ancillary study at four clinical centers p...
What is the current status of trial NCT03179709?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2017-07-01. Estimated completion is 2018-03-18.
What interventions are being tested in trial NCT03179709?
The interventions under investigation include: Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT03179709?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.